NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

You suggest that the FDA lifted the halt because NWBO had decided several months earlier not to enroll any additional patients.

But what if NWBO changed their mind (after the FDA lifted the halt), and decided instead to enroll more patients? You're thinking the FDA would implement the halt again?

It makes more sense, under the circumstances that you're suggesting, that the FDA would want to continue to keep the halt in place.

So for me, the scenario you're suggesting seems a weak one.